4 Largecap DII Backed Fast Revenue Growth and Profit CAGR Stocks to Watch for Future Multibagger Potential: M&M, Cholamandalam, BHEL and Apollo Hospitals

DII backed fast revenue growth and profit CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. M&M, Cholamandalam, BHEL and Apollo Hospitals meet that test, with market caps from Rs 1.28 lakh crore to Rs 4.13 lakh crore and M&M offering the lowest PE of the group at 20.40. Each of these companies has a domestic institutional holding of at least 20 per cent, FY26 revenue growth of at least 15 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a domestic institutional holding of at least 20 per cent, FY26 revenue growth of at least 15 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening DII backed fast revenue growth and profit CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 12 November 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are DII Backed Fast Revenue Growth and Profit CAGR Stocks and Why Do They Attract Multibagger Interest?

DII backed fast revenue growth and profit CAGR stocks are shares of large companies in which domestic funds, insurers and mutual funds together own at least twenty per cent of the business, whose sales grew by fifteen per cent or more in FY26 and whose profit has compounded at fifteen per cent or more a year over four years. The four here cover utility vehicles, vehicle finance, hospitals and heavy electrical equipment.

Domestic funds invest money from Indian savers and study companies in depth, so a large DII stake in a company with fast sales growth and compounding profit shows steady local trust in both the present and the record behind it. Within DII backed fast revenue growth and profit CAGR stocks, the four companies show rising profit. In DII backed fast revenue growth and profit CAGR stocks, each of the four also posted growth in the latest quarter. For DII backed fast revenue growth and profit CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read DII backed fast revenue growth and profit CAGR stocks, the common thread is rising profit backed by complete financial data. For DII backed fast revenue growth and profit CAGR stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of DII backed fast revenue growth and profit CAGR stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for DII backed fast revenue growth and profit CAGR stocks before you decide.

DII Backed Fast Revenue Growth and Profit CAGR Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 12 November 2026. M&M has the lowest PE of the group at 20.40, while Apollo Hospitals posts the highest return on equity at 20.48%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Mahindra & Mahindra	3,399	4,13,069	20.40	23.82	18.37%	4.44	2,744.30 to 3,839.90
Cholamandalam Investment and Finance	1,862	1,64,676	28.63	17.68	17.18%	5.38	1,299.40 to 1,952.50
Bharat Heavy Electricals	431.20	1,63,621	56.82	45.89	10.76%	6.12	229.54 to 464.00
Apollo Hospitals Enterprise	8,515	1,27,763	58.82	60.75	20.48%	13.48	6,696.50 to 9,070.50

M&M: 26.58% Profit CAGR Since FY22

Mahindra & Mahindra is one of the largest SUV makers in India and the country's largest tractor maker, with financial services and electric vehicles in its portfolio. It reported FY26 revenue of Rs 2,02,084.34 crore, up 25.21% year on year, and net profit of Rs 18,621.71 crore, up 32.32%. Net profit has compounded at 26.58% a year since FY22, while revenue has grown 22.04% a year. Operating margin was 21.19% in FY26.

In the June 2026 quarter, revenue rose 27.47% to Rs 59,203.60 crore and net profit grew 37.04% to Rs 5,997.56 crore. The share price has gained 226.46% over five years. Domestic institutions raised their holding from 29.59% in June 2025 to 32.65% in June 2026. The stock trades at a PE of 20.40 against an industry PE of 23.82, below the sector average, with a return on equity of 18.37%.

Cholamandalam: 24.75% Profit CAGR Since FY22

Cholamandalam Investment and Finance, part of the Murugappa Group, offers vehicle finance, home loans and loans against property. It reported FY26 total income of Rs 31,538.73 crore, up 20.60% year on year, and net profit of Rs 5,228.88 crore, up 22.74%. Net profit has compounded at 24.75% a year since FY22, while total income has grown 32.50% a year.

The stock trades at a PE of 28.63 against an industry PE of 17.68, with a return on equity of 17.18%. In the June 2026 quarter, total income rose 21.81% to Rs 8,956.68 crore and net profit grew 45.56% to Rs 1,656.22 crore. The share price has gained 166.38% over five years. Domestic institutions raised their holding from 16.06% in June 2025 to 20.62% in June 2026.

BHEL: 37.73% Profit CAGR Since FY22

Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23.

In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. The share price has gained 523.42% over five years and 97.23% over the past year. Domestic institutions raised their holding from 18.62% in September 2025 to 21.88% in September 2026. The stock trades at a PE of 56.82 against an industry PE of 45.89.

Apollo Hospitals: Return on Equity of 20.48%

Apollo Hospitals Enterprise runs one of India's largest hospital networks and also operates pharmacies and a digital health platform. It reported FY26 revenue of Rs 25,420.10 crore, up 15.58% year on year, and net profit of Rs 2,002.70 crore, up 33.06%. Net profit has compounded at 16.13% a year since FY22, while revenue has grown 14.59% a year. Operating margin was 15.80% in FY26.

The stock trades at a PE of 58.82 against an industry PE of 60.75, below the sector average, with a return on equity of 20.48%. In the June 2026 quarter, revenue rose 20.57% to Rs 7,092.30 crore and net profit grew 38.41% to Rs 610.40 crore. The share price has gained 86.54% over five years. Domestic institutions raised their holding from 21.12% in September 2025 to 22.07% in September 2026.

DII Backed Fast Revenue Growth and Profit CAGR Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these DII backed fast revenue growth and profit CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	4-Year Net Profit CAGR
M&M	2,02,084.34	18,621.71	25.21%	22.04%	26.58%
Cholamandalam	31,538.73	5,228.88	20.60%	32.50%	24.75%
BHEL	34,589.83	1,600.26	20.08%	12.54%	37.73%
Apollo Hospitals	25,420.10	2,002.70	15.58%	14.59%	16.13%

Check the Univest Screener for live data on these DII backed fast revenue growth and profit CAGR stocks

Institutional Holding in M&M, Cholamandalam, BHEL and Apollo Hospitals

Institutional holding shows who is backing these DII backed fast revenue growth and profit CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. M&M has the deepest institutional backing, with FII and DII together holding 67.54% as of June 2026. Domestic institutions increased their holding over the past year in M&M (from 29.59% to 32.65%), Cholamandalam (from 16.06% to 20.62%), BHEL (from 18.62% to 21.88%) and Apollo Hospitals (from 21.12% to 22.07%). To see how this group fits the wider market, many investors compare it with the Nifty 100.

Stock	Promoter	FII	DII	Public	Quarter
M&M	18.45%	34.89%	32.65%	14.01%	June 2026
Cholamandalam	49.22%	24.45%	20.62%	5.70%	June 2026
BHEL	58.17%	9.94%	21.88%	10.02%	September 2026
Apollo Hospitals	28.02%	43.18%	22.07%	6.72%	September 2026

Risks to Weigh in DII Backed Fast Revenue Growth and Profit CAGR Stocks

Being careful with DII backed fast revenue growth and profit CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Cholamandalam trades at a PE of 28.63 against an industry PE of 17.68, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between DII Backed Fast Revenue Growth and Profit CAGR Stocks

Picking from DII backed fast revenue growth and profit CAGR stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (17.68 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track M&M, Cholamandalam, BHEL and Apollo Hospitals live prices.

Conclusion

Among DII backed fast revenue growth and profit CAGR stocks, M&M stands out for the lowest PE of the group at 20.40, Cholamandalam for 20.60% revenue growth in FY26, BHEL for the fastest profit growth, 37.73% a year since FY22 and Apollo Hospitals for the highest return on equity at 20.48%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing DII backed fast revenue growth and profit CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on DII Backed Fast Revenue Growth and Profit CAGR Stocks to Watch

Which are the best DII backed fast revenue growth and profit CAGR stocks to watch for multibagger potential?

Ans. M&M, Cholamandalam, BHEL and Apollo Hospitals are the 4 names this list highlights, with market caps of Rs 4,13,069 crore, Rs 1,64,676 crore, Rs 1,63,621 crore and Rs 1,27,763 crore respectively. M&M is notable for the lowest PE of the group at 20.40. Cholamandalam stands out for 20.60% revenue growth in FY26. BHEL offers the fastest profit growth, 37.73% a year since FY22. Apollo Hospitals brings the highest return on equity at 20.48%. These are watchlist names for DII backed fast revenue growth and profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Apollo Hospitals a good stock for long-term investors?

Ans. Apollo Hospitals has a return on equity of 20.48%, a PE of 58.82 against an industry PE of 60.75 and a market cap of Rs 1,27,763 crore. Net profit has compounded at 16.13% a year since FY22, and FY26 revenue rose 15.58% while June 2026 quarter net profit grew 38.41%. Long-term returns in DII backed fast revenue growth and profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can BHEL become a multibagger from here?

Ans. BHEL has already gained 523.42% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in DII backed fast revenue growth and profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 37.73% a year since FY22, and FY26 revenue rose 20.08%. At a PE of 56.82 against an industry PE of 45.89, valuation should be checked against that growth before investing.

What is the market cap of M&M, Cholamandalam, BHEL and Apollo Hospitals?

Ans. As of 12 November 2026, M&M has a market cap of Rs 4,13,069 crore, Cholamandalam has a market cap of Rs 1,64,676 crore, BHEL has a market cap of Rs 1,63,621 crore and Apollo Hospitals has a market cap of Rs 1,27,763 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on DII backed fast revenue growth and profit CAGR stocks.

What are the risks of investing in DII backed fast revenue growth and profit CAGR stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Cholamandalam trades at a PE of 28.63 against an industry PE of 17.68, so earnings growth needs to hold up.

Why is Cholamandalam trading at a PE of 28.63?

Ans. Cholamandalam's PE of 28.63 compares with an industry PE of 17.68. The market is paying a premium for a return on equity of 17.18%, profit growth of 24.75% a year since FY22 and latest-quarter profit growth of 45.56%, which also means the stock is more sensitive if growth slows. Investors in DII backed fast revenue growth and profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in M&M, Cholamandalam, BHEL and Apollo Hospitals?

Ans. As of the latest reported quarter, FII and DII together hold 67.54% of M&M (34.89% and 32.65%), 45.07% of Cholamandalam (24.45% and 20.62%), 31.82% of BHEL (9.94% and 21.88%) and 65.25% of Apollo Hospitals (43.18% and 22.07%). Rising institutional holding is a useful signal in DII backed fast revenue growth and profit CAGR stocks, though it should be read with earnings trends rather than on its own.